This was in a 10k filed yesterday. It is probably more than you want or need but having found it I feel compelled to post it. Why don't they mention the others? No idea. I have urged XOMA to get something extra for maintaining confidentiality. Am sure they listened. <g>
Cell Expression Systems
XOMA has granted over 20 licenses to biotechnology and pharmaceutical
companies to use its patented and proprietary technologies relating to bacterial
expression of recombinant pharmaceutical products. Licensees include: Affymax
Research Institute, Alexion Pharmaceuticals Inc., Avecia Ltd., Biosite
Diagnostics Incorporated, Cantab Pharmaceuticals Research Ltd., Celltech Ltd.,
Eli Lilly and Company, Enzon, Inc., Genentech, Inc., the Hoechst Group, ICOS
Corporation, Invitrogen Corporation, MorphoSys AG, Pasteur Merieux Serums &
Vaccins, The Pharmacia & Upjohn Group and ZymoGenetics, Inc. |
